RhumbLine Advisers’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
46,770
+1,016
| +2% | +$49.1K | ﹤0.01% | 1821 |
|
|
2025
Q1 | $2.54M | Buy |
45,754
+5,477
| +14% | +$304K | ﹤0.01% | 1697 |
|
|
2024
Q4 | $1.94M | Sell |
40,277
-4,491
| -10% | -$217K | ﹤0.01% | 1893 |
|
|
2024
Q3 | $2.58M | Buy |
44,768
+1,980
| +5% | +$114K | ﹤0.01% | 1762 |
|
|
2024
Q2 | $2.08M | Buy |
42,788
+911
| +2% | +$44.2K | ﹤0.01% | 1861 |
|
|
2024
Q1 | $2.04M | Buy |
41,877
+2,926
| +8% | +$142K | ﹤0.01% | 1908 |
|
|
2023
Q4 | $1.94M | Sell |
38,951
-127
| -0.3% | -$6.32K | ﹤0.01% | 1919 |
|
|
2023
Q3 | $2.1M | Buy |
39,078
+5,370
| +16% | +$288K | ﹤0.01% | 1833 |
|
|
2023
Q2 | $1.82M | Buy |
+33,708
| New | +$1.82M | ﹤0.01% | 1962 |
|
|
2021
Q1 | – | Sell |
-4,519
| Closed | -$220K | – | 3025 |
|
|
2020
Q4 | $220K | Buy |
+4,519
| New | +$220K | ﹤0.01% | 2800 |
|
|
2016
Q3 | – | Sell |
-26,510
| Closed | -$1.11M | – | 2930 |
|
|
2016
Q2 | $1.11M | Hold |
26,510
| – | – | ﹤0.01% | 1722 |
|
|
2016
Q1 | $1.07M | Hold |
26,510
| – | – | ﹤0.01% | 1748 |
|
|
2015
Q4 | $1.13M | Buy |
26,510
+1,800
| +7% | +$76.8K | ﹤0.01% | 1730 |
|
|
2015
Q3 | $1.17M | Hold |
24,710
| – | – | ﹤0.01% | 1667 |
|
|
2015
Q2 | $1.22M | Sell |
24,710
-8,200
| -25% | -$406K | ﹤0.01% | 1734 |
|
|
2015
Q1 | $1.63M | Sell |
32,910
-1,000
| -3% | -$49.4K | ﹤0.01% | 1534 |
|
|
2014
Q4 | $1.55M | Hold |
33,910
| – | – | ﹤0.01% | 1530 |
|
|
2014
Q3 | $1.91M | Hold |
33,910
| – | – | 0.01% | 1345 |
|
|
2014
Q2 | $1.8M | Hold |
33,910
| – | – | 0.01% | 1451 |
|
|
2014
Q1 | $1.77M | Sell |
33,910
-200
| -0.6% | -$10.5K | 0.01% | 1425 |
|
|
2013
Q4 | $1.83M | Buy |
34,110
+18,200
| +114% | +$976K | 0.01% | 1430 |
|
|
2013
Q3 | $806K | Buy |
15,910
+6,300
| +66% | +$319K | ﹤0.01% | 1915 |
|
|
2013
Q2 | $495K | Buy |
+9,610
| New | +$495K | ﹤0.01% | 2264 |
|